• Search
  • Helpdesk
  • Sales contact
  • Cardiology clinical trials

These trials often involve patients with multiple comorbidities who are often elderly. As cardiovascular diseases affect various populations differently, it is key to include a diverse population in your clinical trial.
Moreover, in some indications such as stroke, patients may require support from caregivers, whose perspective must also be considered.
With specific patient profiles, inclusion and exclusion criteria can be particularly strict, and study procedures can also be complex. This creates a challenging operational environment.

In cardiology clinical trials, the use of eCOA has been transformative. It allows for real-time data collection and patient monitoring, which is crucial given the complex comorbidities and elevated age of many participants. This technology not only enhances data accuracy but also ensures diverse patient representation, leading to more comprehensive and reliable results.

Estelle Haenel, Kayentis Chief Medical Officer

At Kayentis, we have the experience of such complex studies. Our expert project teams, our robust data management systems, and our strong and intuitive eCOA solution combine to ensure the success of your trial.

Streamline your cardiology clinical trial with our expert eCOA guidance

Leveraging our extensive experience in cardiology trials, we provide comprehensive support from the moment you start to design your study.

Easily capture crucial trial data with our intuitive eCOA solution for your cardiology studies

Our therapeutic areas

Oncology
Immunology-Inflammatory
Rare disease
Cardiology
Respiratory
Dermatology
Ophthalmology
Metabolic health
Metabolic health
Pediatric